90004-93-6 Usage
Description
2'-Bromo-4'-nitroacetophenone is a chemical compound characterized by the molecular formula C8H6BrNO3. It is a yellow crystalline solid known for its role in the synthesis of pharmaceutical compounds and organic materials.
Uses
Used in Pharmaceutical Industry:
2'-Bromo-4'-nitroacetophenone is utilized as an intermediate in the production of various drugs and organic materials. It plays a crucial role in the synthesis of pharmaceutical compounds, contributing to the development of new medications and therapies.
Used in Chemical Industry:
In the chemical industry, 2'-bromo-4'-nitroacetophenone is employed in research and development. It aids in the creation of new organic materials and contributes to the advancement of chemical processes and technologies.
Safety Note:
It is important to handle 2'-bromo-4'-nitroacetophenone with caution due to its hazardous nature. It may cause skin and eye irritation upon contact, necessitating proper safety measures during its use and manipulation.
Check Digit Verification of cas no
The CAS Registry Mumber 90004-93-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,0,0 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 90004-93:
(7*9)+(6*0)+(5*0)+(4*0)+(3*4)+(2*9)+(1*3)=96
96 % 10 = 6
So 90004-93-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrNO3/c1-5(11)7-3-2-6(10(12)13)4-8(7)9/h2-4H,1H3
90004-93-6Relevant articles and documents
CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS
-
Paragraph 00301, (2013/03/26)
The present invention provides compounds of Formula (Ia): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
MACROCYCLES AS FACTOR XIA INHIBITORS
-
Page/Page column 141, (2011/09/15)
The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
